• KOL
    • Hip Fracture
    • Marc C Hochberg
    • Marc C Hochberg: Influence Statistics

      Marc C Hochberg

      Marc C Hochberg

      Show email address

      Univ. of Maryland, Baltimore, MD | University of Maryland School of Medicine, Baltimore, Maryland, U.S.A.. Electronic address: mhochber@som.umaryland.edu. | Department of ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Marc C Hochberg:Expert Impact

      Concepts for whichMarc C Hochberghas direct influence:Hip fracture,Knee osteoarthritis,Rheumatoid arthritis,Older women,Osteoporotic fractures,Hip osteoarthritis,United states,Knee pain.

      Marc C Hochberg:KOL impact

      Concepts related to the work of other authors for whichfor which Marc C Hochberg has influence:Systemic lupus erythematosus,Knee osteoarthritis,Rheumatoid arthritis,Sle patients,Lupus nephritis,Chronic pain,Physical activity.

      KOL Resume for Marc C Hochberg

      Year
      2022

      Univ. of Maryland, Baltimore, MD

      University of Maryland School of Medicine, Baltimore, Maryland, U.S.A.. Electronic address:

      2021

      University of Maryland School of Medicine, Baltimore, Maryland, USA

      Division of Rheumatology and Clinical Immunology, Department of Medicine

      2020

      Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Md.

      Division of Rheumatology, University of Maryland School of Medicine and VA Maryland Health Care System, Baltimore, MD, USA.

      Department of Medicine, University of Maryland School of Medicine;Medical Care Clinical Center, VA Maryland Health Care System

      University of Maryland School of Medicine, Baltimore, Maryland

      2019

      University of Maryland, School of Medicine, 22 S Greene St, Baltimore, MD 21201, USA.

      2018

      Department of Epidemiology and Public Health, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland, USA

      University of Maryland, School of Medicine, Baltimore, MD

      2017

      University of Maryland, Baltimore, MD, USA

      2016

      University of Maryland School of Medicine, Baltimore, MD, United States

      Dept.s of Med. and Epidemiology & Publ. Hlth., Univ. of Maryland Sch. of Med., Baltimore, MD, USA

      2015

      Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, 10 S. Pine St., MSTF 8-34, 21201, Baltimore, MD, USA

      Health Care System, Baltimore, MD

      University of Maryland, Baltimore, United States

      2014

      University of Maryland School of Medicine Baltimore MD USA

      U. of Maryland School Medicine, Baltimore, United States

      Geriatric Research Education and Clinical Center, VA Maryland Health Care System, Baltimore, MD

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Marc C Hochberg is among the top experts in the world.
      Concept World rank
      severe radiographic knee #1
      phase iii solumatrix #1
      formation bcm #1
      progression hips #1
      arthritis pain exacerbations #1
      cumulative disease #1
      black race morbidity #1
      opportunistic infections irr #1
      time forward direction #1
      definitions rhoa #1
      nsaid users risk #1
      subjects reduced risk #1
      reader agreement differences #1
      oak crp #1
      subjects pivoting #1
      comparative cancer risk #1
      sirs malignancy #1
      hip fracture 10 #1
      knee osteoarthritis acupuncture #1
      route localization #1
      individual radiographic #1
      slower rate decline #1
      alendronate greater gains #1
      entry ses #1
      sprifermin cartilage morphology #1
      morbidity sle #1
      differences readings #1
      forward direction trails #1
      pn400 patients #1
      women southern norway #1
      95 uni wp #1
      incidence rates malignancies #1
      observed irs infections #1
      recommendations hip #1
      ecasa napso #1
      analgesic nsaids #1
      lupus activity lai #1
      acr70 response tocilizumab #1
      context activity level #1
      pretreatment pinp #1
      sprifermin 30 μg #1
      patients oarsi #1
      knee future #1
      incident rhoa subjects #1
      coxibs traditional nsaids #1
      aask womac #1
      knee kellgren #1
      progression radiographic features #1
      new symptom outcome #1
      diacerhein osteoarthritis #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Marc C Hochberg

      KOL-Index: 26596

      To determine the effects of continuation versus discontinuation of alendronate on BMD and markers of bone turnover, we conducted an extension trial in which 1099 older women who received alendronate in the FIT were re-randomized to alendronate or placebo. Compared with women who stopped alendronate, those continuing alendronate for 3 years maintained a higher BMD and greater reduction of bone turnover, showing benefit of continued treatment. However, among women who discontinued ...

      Known for Bone Turnover | Alendronate Bmd | Fracture Intervention Trial | 3 Years | Treatment Women
      KOL-Index: 22533

      PURPOSE: As a prelude to developing updated, evidence-based, international consensus recommendations for the management of hip and knee osteoarthritis (OA), the Osteoarthritis Research Society International (OARSI) Treatment Guidelines Committee undertook a critical appraisal of published guidelines and a systematic review (SR) of more recent evidence for relevant therapies.

      METHODS: Sixteen experts from four medical disciplines (primary care two, rheumatology 11, orthopaedics one and ...

      Known for Critical Appraisal | Knee Osteoarthritis | Treatment Guidelines | Oarsi Recommendations | Management Hip
      KOL-Index: 20942

      Once-weekly alendronate 70 mg and once-weekly risedronate 35 mg are indicated for the treatment of postmenopausal osteoporosis. These two agents were compared in a 12-month head-to-head trial. Greater gains in BMD and greater reductions in markers of bone turnover were seen with alendronate compared with risedronate with similar tolerability.

      INTRODUCTION: The nitrogen-containing bisphosphonates, alendronate and risedronate, are available in once-weekly (OW) formulations for the ...

      Known for Postmenopausal Osteoporosis | Alendronate Risedronate | 12 Months | Hip Trochanter | Bone Turnover
      KOL-Index: 20273

      OBJECTIVE: To update the American College of Rheumatology (ACR) 2000 recommendations for hip and knee osteoarthritis (OA) and develop new recommendations for hand OA.

      METHODS: A list of pharmacologic and nonpharmacologic modalities commonly used to manage knee, hip, and hand OA as well as clinical scenarios representing patients with symptomatic hand, hip, and knee OA were generated. Systematic evidence-based literature reviews were conducted by a working group at the Institute of ...

      Known for Knee Hip | Management Patients | Recommendations Evidence | Pharmacologic Modalities | Osteoarthritis Hand
      KOL-Index: 19690

      PURPOSE: To develop concise, patient-focussed, up to date, evidence-based, expert consensus recommendations for the management of hip and knee osteoarthritis (OA), which are adaptable and designed to assist physicians and allied health care professionals in general and specialist practise throughout the world.

      METHODS: Sixteen experts from four medical disciplines (primary care, rheumatology, orthopaedics and evidence-based medicine), two continents and six countries (USA, UK, France, ...

      Known for Consensus Guidelines | Knee Osteoarthritis | Management Hip | Based Evidence | Chondroitin Sulphate
      KOL-Index: 19581

      Some, but not all, antiresorptive agents have been shown to reduce the risk of nonvertebral fractures. Agents that significantly reduced nonvertebral fracture risk also appear to produce larger mean increases in bone mineral density (BMD) and reductions in biochemical markers (BCM) of bone turnover, compared with other agents. To examine the extent to which increases in BMD and reductions in BCM during antiresorptive therapy are associated with reductions in risk of nonvertebral ...

      Known for Nonvertebral Fractures | Antiresorptive Agents | Bmd Bcm | Bone Density | Larger Increases
      KOL-Index: 19221

      CONTEXT: Black women have a lower rate of fracture than white women, but whether bone mineral density (BMD) predicts fracture risk as well in black women as it does in white women is not established.

      OBJECTIVE: To examine the association between BMD and incident nonspinal fractures in older black and white women.

      DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study of baseline data collected from 1986 through 1990 (7334 white women aged 67-99 years) and from 1996 through 1998 (636 ...

      Known for White Women | Bone Mineral Density | Bmd Risk | Femoral Neck | Fracture Black
      KOL-Index: 18908

      Importance: Sprifermin is under investigation as a disease-modifying osteoarthritis drug.

      Objective: To evaluate the effects of sprifermin on changes in total femorotibial joint cartilage thickness in the more symptomatic knee of patients with osteoarthritis.

      Design, Setting, and Participants: FORWARD (FGF-18 Osteoarthritis Randomized Trial with Administration of Repeated Doses) was a 5-year, dose-finding, multicenter randomized clinical trial conducted at 10 sites. Eligible participants ...

      Known for Articular Sprifermin | Cartilage Thickness | 100 Μg | Femorotibial Joint | 12 Months
      KOL-Index: 17966

      OBJECTIVE: To compare the prevalence of osteoarthritis (OA) of the hip among elderly persons in China and the US.

      METHODS: We recruited a population-based sample of 1,506 persons (82% of those enumerated) ages > or = 60 years living in Beijing, China. Subjects answered questions about joint symptoms and underwent radiography of the pelvis. Radiographs of the Beijing subjects were intermingled with hip radiographs of white women ages > or = 65 years from the Study of Osteoporotic ...

      Known for United States | Radiographic Hip | Low Prevalence | Beijing Osteoarthritis | Chinese Women
      KOL-Index: 17875

      BACKGROUND: Cyclo-oxygenase 2 (COX2)-selective inhibitors should reduce ulcer complications compared with non-selective non-steroidal anti-inflammatory drugs, but evidence is limited, and the possibility that these inhibitors increase cardiovascular events has been raised. The Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET) aimed to assess gastrointestinal and cardiovascular safety of the COX2 inhibitor lumiracoxib compared with two non-steroidal ...

      Known for Ulcer Complications | Ibuprofen Naproxen | Controlled Trial | Cardiovascular Events | Patients Osteoarthritis
      KOL-Index: 17137

      The validity of the WHO 10-yr probability of major osteoporotic fracture model (FRAX) for prediction of vertebral fracture has not been tested. We analyzed how well FRAX for major osteoporotic fractures, with and without femoral neck BMD (FN BMD), predicted the risk of vertebral fracture. We also compared the predictive validity of FRAX, FN BMD, and prevalent vertebral fracture detected by radiographs at baseline alone or in combination to predict future vertebral fracture. We analyzed ...

      Known for Vertebral Fracture | Frax Bmd | Major Osteoporotic | Predicted Risk | Bone Density
      KOL-Index: 17105

      BACKGROUND: The potential for cyclo-oxygenase 2 (COX2)-selective inhibitors to increase the risk for myocardial infarction is controversial. The Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET) aimed to assess gastrointestinal and cardiovascular safety of the COX2 inhibitor lumiracoxib compared with two non-steroidal anti-inflammatory drugs, naproxen and ibuprofen.

      METHODS: 18325 patients age 50 years or older with osteoarthritis were randomised to lumiracoxib 400 ...

      Known for Lumiracoxib Ibuprofen | Myocardial Infarction | Controlled Trial | Patients Aspirin | Primary Endpoint
      KOL-Index: 17096

      BACKGROUND: Each year, clinical upper gastrointestinal events occur in 2 to 4 percent of patients who are taking nonselective nonsteroidal antiinflammatory drugs (NSAIDs). We assessed whether rofecoxib, a selective inhibitor of cyclooxygenase-2, would be associated with a lower incidence of clinically important upper gastrointestinal events than is the nonselective NSAID naproxen among patients with rheumatoid arthritis.

      METHODS: We randomly assigned 8076 patients who were at least 50 ...

      Known for Rheumatoid Arthritis | Rofecoxib Naproxen | Upper Gastrointestinal | Selective Inhibitor | 2 Cyclooxygenase
      KOL-Index: 17007

      BACKGROUND: Frailty, as defined by the index derived from the Cardiovascular Health Study (CHS index), predicts risk of adverse outcomes in older adults. Use of this index, however, is impractical in clinical practice.

      METHODS: We conducted a prospective cohort study in 6701 women 69 years or older to compare the predictive validity of a simple frailty index with the components of weight loss, inability to rise from a chair 5 times without using arms, and reduced energy level (Study of ...

      Known for Older Women | Chs Sof | Risk Falls | Hazard Ratio | Fractures Death
      KOL-Index: 16688

      BACKGROUND: Osteoarthritis (OA) is the most common form of arthritis, and it is often associated with significant disability and an impaired quality of life.

      OBJECTIVES: To review all randomized controlled trials (RCTs) evaluating the effectiveness and toxicity of glucosamine in OA.

      SEARCH STRATEGY: We searched MEDLINE, PREMEDLINE, EMBASE, AMED, ACP Journal Club, DARE, CDSR, and the CCTR. We also wrote letters to content experts, and hand searched reference lists of identified RCTs and ...

      Known for Glucosamine Placebo | Smd 95 | Womac Pain Function | Statistical Significance | Randomized Controlled Trials

      Key People For Hip Fracture

      Top KOLs in the world
      #1
      Cyrus C Cooper
      hip fracture grip strength hertfordshire cohort study
      #2
      Steven Ron Cummings
      hip fracture breast cancer older women
      #3
      Lee Joseph Melton,
      olmsted county fracture risk irritable bowel syndrome
      #4
      John A Kanis
      hip fracture postmenopausal women intervention thresholds
      #5
      Jay S Magaziner
      hip fracture nursing homes zoledronic acid
      #6
      Olof Johnell
      hip fracture bone mineral density internal fixation

      Univ. of Maryland, Baltimore, MD | University of Maryland School of Medicine, Baltimore, Maryland, U.S.A.. Electronic address: mhochber@som.umaryland.edu. | Department of Epidemiology and Public Health, University of Maryland School of Medicine, Balt

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.